bluebird bio Stock Price (NASDAQ:BLUE)

Add to My Stocks
$140 $2.8 (2.04%) BLUE stock closing price Sep 18, 2018 (Closing)
Prev Close* : $137.2
Market Cap:
$7.43B
Day Low: $134.5
52 Week Low: $119.90
Open: $136.85
Volume: -
Day High: $140.45
52 Week High: $236.17
Dividend:
0.00

Latest Stock Market News

Latest Articles

bluebird bio News - From Partners

Upcoming Earnings to Watch: KR, PLAY, TLRD   by Zacks on Sep 07, 2018
O Canada...We're Waiting On You   by Zacks on Aug 30, 2018
Turkey Ruins Week for Dow, S&P   by Zacks on Aug 13, 2018

BLUE Stockcharts

View BLUE PE ratio, PS ratio stocks charts and compare with peers.
BLUE Chart
Note: Compare bluebird bio stock price history with the index and industry peers.

bluebird bio Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
196.72
PB ratio (
price to book ratio
)
5.02

bluebird bio Returns

ROE
(return on equity)
-33%

bluebird bio Financial Ratios

Asset Turnover
0.02
Receivables Turnover
17.53
Debt to Equity
0
Dividend Yield
0%

BLUE Industry Peers

Company Price Change (%)
Beigene (BGNE)160.750.75 (0.47%)
Qiagen (QGEN)38.120.7 (1.87%)
Global Blood Therapeutics (GBT)41.20 (0%)
Glycomimetics (GLYC)14.580.67 (4.82%)
Editas (EDIT)32.820.95 (2.98%)
Intellia Therapeutics (NTLA)31.982.13 (7.14%)
Bellicum (BLCM)6.280.08 (1.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ZIOPHARM Oncology (ZIOP)30.29 (10.7%)
Fate Therapeutics (FATE)12.21.13 (10.21%)
Array BioPharma (ARRY)14.670.94 (6.85%)
Verastem (VSTM)8.760.52 (6.31%)
Puma Biotech (PBYI)46.752.65 (6.01%)
Cara Therapeutics (CARA)22.381.18 (5.57%)
Exelixis (EXEL)16.670.8 (5.04%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 19, 2018
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)2.6250.18 (6.43%)
ELOXX PHARMACT (ELOX)13.350.81 (5.72%)
Alder BioPharma (ALDR)16.350.7 (4.11%)
AMAG Pharma (AMAG)20.950.7 (3.23%)
Enzo Biochem (ENZ)4.540.13 (2.78%)
Amarin (AMRN)2.760.07 (2.47%)
Idera Pharma (IDRA)7.990.2 (2.44%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 19, 2018

bluebird bio Inc Stock News - Partner Headlines

bluebird bio Financial Statements

income statement20172016201520142013
Net Sales or Revenues35.42M6.15M14.07M25.42M20.18M
Net Income-335.64M-263.5M-166.78M-48.7M-25.32M
Total Operating Expense366.06M273.98M183.1M86.04M45.12M
View bluebird bio income statement
balance sheet20172016201520142013
Total Assets1.9B1.12B1B556.73M224.39M
Total Liabilities277.13M248.68M151.84M65.48M72.72M
Shareholders Equity1.62B869.44M850.49M491.25M151.66M
View bluebird bio balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-12.69M18.95M15.95M-14.73M60.89M
Net Cash from (used by) Operating Activities-280.55M-189.64M-98.42M-59.69M43.45M
Increase (Decrease) in Prop Plant And Equipment-62.24M-15.99M-7.05M-8.7M-8.67M
View bluebird bio cash flow statement

bluebird bio Stock Message Board

bluebird bio stock gained 2.04%, and the last close price as of Sep 18, 2018 is $140 for BLUE stock. Looking at bluebird bio market capitalization, which currently stands at $7.43B, we can say that BLUE stock is a Mid Cap stock. A value investor must look at the fundamentals of a stock, and perform bluebird bio valuation, even though in the short-term, sentiment and current breaking news might affect bluebird bio stock price.

The terms stocks and shares mean the same thing. For Ex: bluebird bio stock price and bluebird bio share price mean the same thing. The volume number in bluebird bio stock quote data shows the number of shares traded. For Ex: 729,384 bluebird bio shares were traded as of last trading day, as seen from bluebird bio stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. bluebird bio dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking bluebird bio stock price history.